Experience with carboplatin and etoposide maintenance chemotherapy in patients with extensive stage small cell lung cancer

JOURNAL ARTICLE published August 2011 in Lung Cancer: Targets and Therapy

Authors: Amaan Siddiqi

The role of maintenance pemetrexed in the treatment of non-small-cell lung cancer

JOURNAL ARTICLE published July 2010 in Lung Cancer: Targets and Therapy

Targeting PD-1/PD-L1 in lung cancer: current perspectives

JOURNAL ARTICLE published July 2015 in Lung Cancer: Targets and Therapy

Authors: Rafael Rosell | Maria Gonzalez-Cao | Niki Karachaliou | Santiago Viteri | Daniela Morales Espinosa | Cristina Teixidó | Jesus Sanchez Ruiz | Miguel Angel Molina-Vila | Mariacarmela Santarpia

Hypersensitivity in ALK-positive lung cancers exposed to ALK inhibitors: a case of successful switch to an alternative ALK inhibitor and systematic review of the literature

JOURNAL ARTICLE published September 2018 in Lung Cancer: Targets and Therapy

Authors: Lei Deng | Janaki Sharma | Elizabeth Ravera | Balazs Halmos | Haiying Cheng

<p>Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (<em>ALK</em>)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies</p>

JOURNAL ARTICLE published November 2019 in Lung Cancer: Targets and Therapy

Authors: Shirish Gadgeel | Alice T Shaw | Fabrice Barlesi | Lucio Crino | James CH Yang | Anne-Marie Dingemans | Dong-Wan Kim | Filippo de Marinis | Mathias Schulz | Shiyao Liu | Ravindra Gupta | Vlatka Smoljanovic | Sai-Hong Ignatius Ou

Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges

JOURNAL ARTICLE published August 2017 in Lung Cancer: Targets and Therapy

Authors: Dionisios Spyratos | Eleni Papadaki | Sofia Lampaki | Theodoros Kontakiotis

Optimal delivery of follow-up care following pulmonary lobectomy for lung cancer

JOURNAL ARTICLE published March 2016 in Lung Cancer: Targets and Therapy

Authors: Shih-Chun Lee | Ying-Yi Chen | Tsai-Wang Huang | Hung Chang

The Additional Exclusions of ROS1 Fusions (In Addition to EGFR Mutation and ALK Fusions) in the Cemiplimab NSCLC FDA Indication (EMPOWER-Lung 1 and -Lung 3). Catching Up with Current Scientific View of Immunotherapy in Never-Smoker Predominant Actionable Driver Mutation Positive NSCLC?

JOURNAL ARTICLE published June 2023 in Lung Cancer: Targets and Therapy

Authors: Danielle Brazel | Saihong Ignatius Ou

Immunotherapy for Stage III NSCLC: Durvalumab and Beyond

JOURNAL ARTICLE published November 2021 in Lung Cancer: Targets and Therapy

Authors: Orla Fitzpatrick | Jarushka Naidoo

<p>Symptomatic CNS Radiation Necrosis Requiring Neurosurgical Resection During Treatment with Lorlatinib in ALK-Rearranged NSCLC: A Report of Two Cases</p>

JOURNAL ARTICLE published January 2020 in Lung Cancer: Targets and Therapy

Authors: Viola W Zhu | Misako Nagasaka | Takafumi Kubota | Kunil Raval | Natasha Robinette | Octavio Armas | Wajd Al-Holou | Sai-Hong Ignatius Ou

Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma

JOURNAL ARTICLE published August 2016 in Lung Cancer: Targets and Therapy

Authors: Seigo Minami | Yoshitaka Ogata | Shouichi Ihara | Suguru Yamamoto | Kiyoshi Komuta

Lung cancer in women

JOURNAL ARTICLE published December 2012 in Lung Cancer: Targets and Therapy

Authors: Raul Barrera | Jorge Morales Fuentes

<p>Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non–Small Cell Lung Cancer: Emerging Mechanisms and Perspectives</p>

JOURNAL ARTICLE published January 2020 in Lung Cancer: Targets and Therapy

Authors: Hiroyuki Inoue | Isamu Okamoto

Spotlight on brigatinib and its potential in the treatment of patients with metastatic ALK-positive non-small cell lung cancer who are resistant or intolerant to crizotinib

JOURNAL ARTICLE published October 2017 in Lung Cancer: Targets and Therapy

Authors: Rohit K Jain | Hongbin Chen

Prognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell lung cancer &ndash; significance and development

JOURNAL ARTICLE published October 2017 in Lung Cancer: Targets and Therapy

Authors: Roberto Cascone | Annalisa Carlucci | Matteo Pierdiluca | Mario Santini | Alfonso Fiorelli

<p>Incidence of <em>ROS1</em>-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients</p>

JOURNAL ARTICLE published February 2020 in Lung Cancer: Targets and Therapy

Authors: Anurag Mehta | Mumtaz Saifi | Ullas Batra | M Suryavanshi | Kush Gupta

Emerging treatments in lung cancer &ndash; targeting the RLIP76 molecular transporter

JOURNAL ARTICLE published November 2013 in Lung Cancer: Targets and Therapy

Authors: Lawrence Goldfinger | Seunghyung Lee

Afatinib treatment in advanced non-small cell lung cancer

JOURNAL ARTICLE published October 2011 in Lung Cancer: Targets and Therapy

Authors: Lynn Campbell

AXL receptor tyrosine kinase as a therapeutic target in NSCLC

JOURNAL ARTICLE published April 2015 in Lung Cancer: Targets and Therapy

Authors: Trever Bivona | Ross Okimoto

Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer

JOURNAL ARTICLE published December 2017 in Lung Cancer: Targets and Therapy

Authors: Seigo Minami | Yoshitaka Ogata | Shouichi Ihara | Suguru Yamamoto | Kiyoshi Komuta